Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain

被引:15
作者
Portillo, A
Lantero, M
Gastañares, MJ
Ruiz-Larrea, F
Torres, C
机构
[1] Univ La Rioja, Area Bioquim & Biol Mol, Logrono, Spain
[2] Hosp San Millan, Microbiol Lab, Logrono, Spain
关键词
Streptococcus pyogenes; macrolides; mechanisms of resistance;
D O I
10.1016/S0924-8579(99)00104-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
One hundred and thirty seven consecutive clinical Streptococcus pyogenes isolates were evaluated for macrolide-lincosamide-streptogramin resistance (MLS). Forty of these isolates were resistant to erythromycin (29.2%), 36 of them showed the new M resistance phenotype (erythromycin resistant and clindamycin susceptible) and four isolates had the MLSB resistance phenotype (erythromycin and clindamycin resistant). In all 36 isolates with the M resistance phenotype, the mef gene was identified by polymerase chain reaction (PCR). In two of the four S. pyogenes isolates with the MLSB phenotype both ermB and ermTR genes were found; negative results were obtained with the other two isolates which might possess a new mechanism of high level resistance against erythromycin not previously described. In summary, a high rate of erythromycin resistance was found in S. pyogenes isolates and the active efflux pump mediated by the mef gene was the mechanism most frequently involved. (C) 1999 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 36 条
  • [1] Arthur Michel, 1993, P534
  • [2] Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA
    Barry, AL
    Fuchs, PC
    Brown, SD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 139 - 140
  • [3] IN-VITRO ACTIVITIES OF 12 ORALLY-ADMINISTERED ANTIMICROBIAL AGENTS AGAINST 4 SPECIES OF BACTERIAL RESPIRATORY PATHOGENS FROM US-MEDICAL-CENTERS IN 1992 AND 1993
    BARRY, AL
    PFALLER, MA
    FUCHS, PC
    PACKER, RR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) : 2419 - 2425
  • [4] Bellido J L, 1998, Rev Esp Quimioter, V11, P196
  • [5] Bisno A., 1995, PRINCIPLES PRACTICE, P1786
  • [6] A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy
    Borzani, M
    DeLuca, M
    Varotto, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) : 457 - 458
  • [7] CAPARON MG, 1991, METHOD ENZYMOL, V204, P556
  • [8] Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes
    Clancy, J
    Petitpas, J
    DibHajj, F
    Yuan, W
    Cronan, M
    Kamath, AV
    Bergeron, J
    Retsema, JA
    [J]. MOLECULAR MICROBIOLOGY, 1996, 22 (05) : 867 - 879
  • [9] High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: An epidemiological and molecular study
    Cocuzza, CE
    Mattina, R
    Mazzariol, A
    Orefici, G
    Rescaldani, R
    Primavera, A
    Bramati, S
    Masera, G
    Parizzi, F
    Cornaglia, G
    Fontana, R
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (04): : 371 - 378
  • [10] COLODNER P, 1997, 8 EUR C CLIN MICR IN